Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2021
>
Bristol-Myers, Sanofi ordered to pay Hawaii $834 million over Plavix warning label
Bristol-Myers, Sanofi ordered to pay Hawaii $834 million over Plavix warning label
Read also
FDA Fast-Tracks 6 More Drugs - Obesity And Cancer Drugs Included
On Thursday, the U.S. Food and Drug Administration (FDA) announced six additional awardees under the Commissioner's National Priority Voucher (CNPV) pilot program.
Lupin's Bioresearch Center Aces U.S. FDA Inspection with Zero Observations
Lupin Limited, a global pharmaceutical leader, has announced a significant milestone for its Bioresearch Center in Pune.
FDA warns 18 websites for selling fake Botox linked to injuries
U.S. regulators have issued warnings to 18 websites that were selling fake or unapproved versions of Botox and similar wrinkle-relaxing injections.
Sana, CAMP4
Sana Biotechnology, CAMP4 Therapeutics and Crinetics Pharmaceuticals have all used the third quarter to refocus their pipelines on the most promising candidates.
